Saliva Pepsin Concentration of Laryngopharyngeal Reflux Patients Is Influenced by Meals Consumed Before the Samples
- PMID: 32510588
- DOI: 10.1002/lary.28756
Saliva Pepsin Concentration of Laryngopharyngeal Reflux Patients Is Influenced by Meals Consumed Before the Samples
Abstract
Objectives/hypothesis: To assess the impact of diet on the saliva pepsin concentration of patients with laryngopharyngeal reflux (LPR).
Study design: Non-controlled Prospective Study.
Methods: Patients with positive LPR regarding hypopharyngeal-esophageal impedance-pH monitoring (HEMII-pH) were enrolled from three European Hospitals. Patients collected three saliva samples, respectively, in the morning (fasting), and 1 to 2 hour after lunch and dinner. Patients carefully detailed foods and beverages consumed during meals and before the pepsin samples. The 3-month treatment was based on the association of diet, proton pump inhibitors, alginate, or magaldrate regarding the HEMII-pH characteristics. Reflux Symptom Score (RSS) and Reflux Sign Assessment (RSA) were used for assessing the pre- to posttreatment clinical evolution. The Refluxogenic Diet Score and the Refluxogenic Score of a Dish (RESDI) were used to assess the refluxogenic potential of foods and beverages. The relationship between saliva pepsin concentration, HEMII-pH, RESDI, RSS, and RSA was investigated through multiple linear regression.
Results: Forty-two patients were included. The saliva pepsin concentration of the 24-hour period of testing was significantly associated with foods and beverages consumed during the testing period and the evening dinner (rs = 0.973, P < .001). RSS and RSA significantly improved throughout treatment. The level of saliva pepsin in the morning was a negative predictive factor of the therapeutic response regarding RSA and RSS (P < .036).
Conclusions: Foods and beverages may significantly impact the saliva pepsin concentration of patients with LPR. Patients with high-level saliva pepsin in the morning had lower therapeutic response compared with those with low-level saliva pepsin.
Level of evidence: 4 Laryngoscope, 131:350-359, 2021.
Keywords: Reflux; beverages; diet; foods; laryngitis; laryngopharyngeal; pepsin; saliva.
© 2020 The American Laryngological, Rhinological and Otological Society, Inc.
Similar articles
-
Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux Patients.Laryngoscope. 2021 Feb;131(2):268-276. doi: 10.1002/lary.28736. Epub 2020 May 21. Laryngoscope. 2021. PMID: 32438465
-
Does Pepsin Saliva Concentration (Peptest™) Predict the Therapeutic Response of Laryngopharyngeal Reflux Patients?Ann Otol Rhinol Laryngol. 2021 Sep;130(9):996-1003. doi: 10.1177/0003489420986347. Epub 2021 Jan 19. Ann Otol Rhinol Laryngol. 2021. PMID: 33467863
-
Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring.Eur Arch Otorhinolaryngol. 2020 Feb;277(2):511-520. doi: 10.1007/s00405-019-05711-2. Epub 2019 Nov 2. Eur Arch Otorhinolaryngol. 2020. PMID: 31679054
-
Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux.Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3389-3404. doi: 10.1007/s00405-019-05631-1. Epub 2019 Sep 12. Eur Arch Otorhinolaryngol. 2019. PMID: 31515662
-
Review of management of laryngopharyngeal reflux disease.Eur Ann Otorhinolaryngol Head Neck Dis. 2021 Sep;138(4):257-267. doi: 10.1016/j.anorl.2020.11.002. Epub 2020 Nov 27. Eur Ann Otorhinolaryngol Head Neck Dis. 2021. PMID: 33257265 Review.
Cited by
-
Laryngopharyngeal Reflux: A State-of-the-Art Algorithm Management for Primary Care Physicians.J Clin Med. 2020 Nov 10;9(11):3618. doi: 10.3390/jcm9113618. J Clin Med. 2020. PMID: 33182684 Free PMC article. Review.
-
Diagnostic Value of the PeptestTM in Detecting Laryngopharyngeal Reflux.J Clin Med. 2021 Jul 5;10(13):2996. doi: 10.3390/jcm10132996. J Clin Med. 2021. PMID: 34279479 Free PMC article.
-
The study of laryngopharyngeal reflux needs adequate animal model.Eur Arch Otorhinolaryngol. 2022 Jun;279(6):3227-3228. doi: 10.1007/s00405-022-07314-w. Epub 2022 Feb 19. Eur Arch Otorhinolaryngol. 2022. PMID: 35182184 No abstract available.
-
European clinical practice guideline: managing and treating laryngopharyngeal reflux disease.Eur Arch Otorhinolaryngol. 2024 Dec 24. doi: 10.1007/s00405-024-09181-z. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 39719472
-
In response to the importance of 24-h hypopharyngeal-esophageal impedance-pH monitoring for the treatment of laryngopharyngeal reflux.Eur Arch Otorhinolaryngol. 2022 Nov;279(11):5483-5484. doi: 10.1007/s00405-022-07628-9. Epub 2022 Aug 27. Eur Arch Otorhinolaryngol. 2022. PMID: 36029322 No abstract available.
References
BIBLIOGRAPHY
-
- Lechien JR, Akst LM, Hamdan AL, et al. Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Head Neck Surg 2019;160:762-782.
-
- Johnston N, Knight J, Dettmar PW, Lively MO, Koufman J. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope 2004;114:2129-2134.
-
- Johnston N, Wells CW, Samuels TL, Blumin JH. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells. Ann Otol Rhinol Laryngol 2009;118:677-685.
-
- Potluri S, Friedenberg F, Parkman HP, et al. Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung. Dig Dis Sci 2003;48:1813-1817.
-
- Wang J, Zhao Y, Ren J, Xu Y. Pepsin in saliva as a diagnostic biomarker in laryngopharyngeal reflux: a meta-analysis. Eur Arch Otorhinolaryngol 2018;275:671-678.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials